Bajaj Finance Ltd. moves to reshape its capital structure

The Rs 17,500 crore raise should materially strengthen Bajaj Finance’s Tier-1 capital and help preserve CAR as the loan book expands, but the post-raise ratios cannot be calculated from the disclosed information. The amount is a maximum proposed raise, comprising a QIP of up to Rs 11,700 crore ^[1] and promoter warrants of up to Rs 5,800 crore ^[2]; it remains subject to shareholder and regulatory approvals ^[1].

Capital impact

• Bajaj Finance reported a consolidated CAR of 20.90% and Tier-1 capital ratio of 20.01% as of 30 June 2026 ^[3].
• The QIP consists of equity shares ^[2], while the warrants are convertible into equivalent equity shares ^[4]. Once issued and recognised for regulatory capital purposes, the proceeds should flow predominantly into Tier-1 capital rather than Tier-2 capital.
• The entire Rs 17,500 crore will not necessarily be available immediately. For the Rs 5,800 crore warrant component, 25% is payable on allotment and 75% on conversion within 18 months ^[4]. Mechanically, this represents Rs 1,450 crore upfront and Rs 4,350 crore later, derived from the Rs 5,800 crore warrant size ^[2] and the 25%/75% payment terms ^[4].
• The precise increase in CAR is:

`CAR uplift = recognised incremental capital / risk-weighted assets`

Since the filing does not provide the post-issue risk-weighted asset base or the final capital-recognition timing, a defensible post-raise CAR or Tier-1 percentage cannot be stated.

Fit with asset-growth guidance

Management had maintained 22-24% AUM growth guidance for FY26-27 ^[5]. Its longer-term AUM growth corridor was 23-25% ^[3]. Against that growth ambition, the capital raise provides a meaningful cushion: it can support balance-sheet expansion while limiting the need to rely solely on retained earnings or additional leverage.

The key analytical point is that the capital buffer will not automatically translate into a higher reported CAR. If the company deploys the capital rapidly into loans, risk-weighted assets will also rise and absorb part of the benefit. The likely outcome is therefore greater capacity to sustain the targeted growth rate while keeping CAR and Tier-1 ratios comfortably supported, rather than a permanently large one-time increase in the ratios.

One temporal qualification matters: the cited 22-24% guidance is for FY26-27, while the board approval occurred in October 2026. A separate numeric FY27-28 AUM-growth target is not stated in the cited material.

The proposed Rs 17,500 crore raise is a step-change in size, not a response to a clear leverage spike. It is approximately 3.15x the combined Rs 5,560 crore raised through the two 2024 equity transactions—Rs 2,000 crore via rights issue and Rs 3,560 crore through a fresh issue—and is therefore about 214.75% larger ^{[1] [3]}.

The company materials report a consolidated leverage ratio, rather than a separately defined event-date debt-to-equity ratio. That is the closest comparable measure. On that basis, leverage around the 2024 issues was broadly similar to the latest disclosed 4.9x level, rather than materially lower or higher ^{[3] [5]}.

What this implies about headroom: management appears to view the current leverage position as acceptable but not sufficient for its desired growth trajectory without adding capital. The Q1 FY27 management commentary reportedly said that no immediate equity raise was planned at 4.9x leverage, yet the board subsequently approved a much larger raise. That change suggests a shift from relying on existing headroom to proactively securing balance-sheet capacity for future lending growth and capital-adequacy protection ^{[5] [1]}.

The raise is also not entirely immediate equity: Rs 11,700 crore is a QIP, while Rs 5,800 crore is through promoter warrants; only 25% of the warrant consideration is payable on allotment, with the balance due on conversion within 18 months ^{[2] [2] [4]}. Therefore, the headline Rs 17,500 crore represents the maximum potential capital envelope, not necessarily day-one equity infusion.

Analyst inference: this looks more like pre-emptive capacity building than balance-sheet repair. Management appears unwilling to run leverage materially higher without replenishing equity, indicating that the practical growth headroom at roughly 4.9x leverage is viewed as finite even though capital adequacy remained strong at 20.90% in Q1 FY27 ^[3].

The board has approved a maximum Rs 17,500 Crore capital raise: Rs 11,700 Crore through the QIP and Rs 5,800 Crore through preferential warrants. This represents an allocation of 66.86% to the QIP and 33.14% to the warrants, calculated from the disclosed ceilings.^[1][2]

† Derived from the two disclosed issue ceilings. The warrants therefore imply Rs 1,450 Crore payable initially and Rs 4,350 Crore on conversion, assuming the full Rs 5,800 Crore allotment.

Dilution and RoE effect

An exact dilution percentage cannot yet be calculated. The disclosure does not provide the current outstanding share count or final issue/conversion prices; moreover, the filing states that the warrant price will be determined later.^[4] The face value of Re 1 per share does not determine the number of shares issued.

For full conversion, the calculation would be:

• New QIP shares = Rs 11,700 Crore × 1 crore / QIP price per share
• New warrant shares = Rs 5,800 Crore × 1 crore / warrant conversion price per share
• Dilution = new shares / existing shares plus new shares

The effect on RoE is a denominator issue, not simply a share-count issue. Bajaj Finance’s latest TTM consolidated RoE was 19.6%,^[6] against TTM consolidated PAT of Rs 20,647.7 Crore.^[7]

As a mechanical, static sensitivity—assuming the full Rs 17,500 Crore is added immediately to equity and generates no incremental earnings—the implied pre-raise equity base is approximately Rs 105,345 Crore, derived from PAT divided by reported RoE. Post-raise RoE would be approximately:

Rs 20,647.7 Crore / (Rs 105,345 Crore + Rs 17,500 Crore) = 16.81%

That implies a decline of roughly 2.79 percentage points from 19.6%. This is not a management forecast: the actual impact will depend on issue prices, timing of allotment and warrant conversion, the portion of proceeds deployed into earning assets, and the incremental earnings generated.